VitaSpring Biomedical Co. Ltd.
VSBC
$0.01
-$0.24-95.56%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.20K | 2.10K | 2.00K | 800.00 | -- |
| Total Receivables | -- | -- | 200.00 | 200.00 | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.60K | 8.40K | 7.70K | 6.90K | 300.00 |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 9.80K | 10.50K | 9.80K | 7.90K | 300.00 |
|
|
|||||
| Total Current Assets | 9.80K | 10.50K | 9.80K | 7.90K | 300.00 |
| Net Property, Plant & Equipment | 1.70K | 4.10K | 6.60K | 9.10K | 11.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 11.40K | 14.70K | 16.50K | 17.00K | 11.90K |
|
|
|||||
| Total Accounts Payable | 3.12M | 3.06M | 3.02M | 2.97M | 2.94M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.40M | 1.38M | 1.35M | 1.25M | 1.17M |
| Total Other Current Liabilities | 1.40M | 1.38M | 1.35M | 1.25M | 1.17M |
| Total Current Liabilities | 4.52M | 4.45M | 4.37M | 4.22M | 4.11M |
|
|
|||||
| Total Current Liabilities | 4.52M | 4.45M | 4.37M | 4.22M | 4.11M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.52M | 4.45M | 4.37M | 4.22M | 4.11M |
|
|
|||||
| Common Stock & APIC | 1.27M | 1.27M | 1.27M | 1.27M | 1.27M |
| Retained Earnings | -5.77M | -5.70M | -5.62M | -5.47M | -5.36M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -4.51M | -4.43M | -4.35M | -4.21M | -4.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.51M | -4.43M | -4.35M | -4.21M | -4.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.51M | -4.43M | -4.35M | -4.21M | -4.10M |
|
|
|||||